Events

Stronger Shields for Seniors: Respiratory Protection with High-Dose Flu and Recombinant Protein non-mRNA COVID Vaccine Strategies

This webinar will explore evidence-based approaches to protecting respiratory health in LTC settings, with a focus on high dose influenza vaccine and a recombinant protein, non-mRNA COVID-19 vaccine option. Sanofi’s medical directors, Dr. Morgan Anderson and Dr. Katie Sharff, will share insights on the latest influenza vaccine pooled analysis FLUNITY-HD and discuss evolving data on the recombinant protein, non-mRNA COVID-19 vaccine. They will be joined by Dr. Chad Worz, CEO of the American Society of Consultant Pharmacists (ASCP), to provide expert perspectives on clinical implications and practical applications for elder care.